HP1BP3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.356570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.900300E-02
Normal-vs-Stage2
1.552820E-01
Normal-vs-Stage3
3.606500E-02
Normal-vs-Stage4
6.851000E-01
Stage1-vs-Stage2
3.595800E-01
Stage1-vs-Stage3
3.180000E-01
Stage1-vs-Stage4
1.882090E-02
Stage2-vs-Stage3
1.025580E-01
Stage2-vs-Stage4
2.464200E-02
Stage3-vs-Stage4
1.790280E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.335630E-01
Normal-vs-AfricanAmerican
5.465400E-01
Normal-vs-Asian
1.045590E-01
Caucasian-vs-AfricanAmerican
4.589000E-01
Caucasian-vs-Asian
4.072600E-01
AfricanAmerican-vs-Asian
3.422000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.657800E-02
Normal-vs-Female
2.430200E-01
Male-vs-Female
1.358610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.595900E-02
Normal-vs-Age(41-60Yrs)
3.460200E-01
Normal-vs-Age(61-80Yrs)
1.055790E-01
Normal-vs-Age(81-100Yrs)
1.767660E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.415600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.015200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.888800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.881400E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.440900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.915400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.709610E-02
Normal-vs-Daily Drinker
2.356800E-01
Normal-vs-Weekly Drinker
1.769380E-01
Normal-vs-Occasional Drinker
4.592600E-01
Normal-vs-Social Drinker
3.174200E-01
Non Drinker-vs-Daily Drinker
1.731620E-01
Non Drinker-vs-Weekly Drinker
2.031000E-01
Non Drinker-vs-Occasional Drinker
8.782700E-03
Non Drinker-vs-Social Drinker
5.323700E-02
Daily Drinker-vs-Weekly Drinker
9.641200E-01
Daily Drinker-vs-Occasional Drinker
3.100200E-01
Daily Drinker-vs-Social Drinker
6.264800E-01
Weekly Drinker-vs-Occasional Drinker
3.038000E-01
Weekly Drinker-vs-Social Drinker
5.993800E-01
Occasional Drinker-vs-Social Drinker
6.259600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.541000E-01
Normal-vs-Grade 2
7.956200E-01
Normal-vs-Grade 3
8.137600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.322230E-02
Grade 1-vs-Grade 3
5.647500E-02
Grade 1-vs-Grade 4
9.541000E-01
Grade 2-vs-Grade 3
7.209800E-01
Grade 2-vs-Grade 4
7.956200E-01
Grade 3-vs-Grade 4
8.137600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.636500E-02
Normal-vs-NonDiabetic
1.167390E-01
Diabetic-vs-NonDiabetic
4.254000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.207200E-01
Normal-vs-NoPancreatitis
1.011210E-01
Pancreatitis-vs-NoPancreatitis
3.513600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.179440E-01
Normal-vs-N1
1.597810E-01
N0-vs-N1
4.520200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.724600E-01
Normal-vs-TP53-NonMutant
1.368960E-01
TP53-Mutant-vs-TP53-NonMutant
1.234260E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
